SEB Asset Management AB Makes New $6.39 Million Investment in GE HealthCare Technologies Inc. $GEHC

SEB Asset Management AB bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 89,796 shares of the company’s stock, valued at approximately $6,392,000.

A number of other institutional investors and hedge funds have also made changes to their positions in GEHC. Vanguard Group Inc. lifted its stake in shares of GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Auto Owners Insurance Co boosted its position in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Dodge & Cox grew its stake in GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares during the last quarter. Capital Research Global Investors grew its stake in GE HealthCare Technologies by 1.6% in the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after purchasing an additional 389,796 shares during the last quarter. Finally, State Street Corp raised its holdings in GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after purchasing an additional 401,932 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $62.04 on Wednesday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The company has a market cap of $28.22 billion, a PE ratio of 14.84, a price-to-earnings-growth ratio of 1.71 and a beta of 0.72. The company’s 50 day moving average is $63.66 and its 200 day moving average is $71.60.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

Insider Activity at GE HealthCare Technologies

In related news, insider Frank R. Jimenez purchased 1,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the transaction, the insider owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Rodney F. Hochman purchased 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was bought at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 21,847 shares of company stock valued at $1,361,355 over the last ninety days. Corporate insiders own 0.36% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the subject of several analyst reports. HSBC decreased their price target on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Jefferies Financial Group reduced their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research report on Wednesday, April 29th. Argus lowered their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Tuesday, May 19th. Finally, Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $76.41.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.